Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-052735
Filing Date
2010-03-10
Accepted
2010-03-10 17:11:40
Documents
5
Period of Report
2009-12-26

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 919282
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex23.htm EX-23 2153
3 RULE 13A-14(A)/ 15D-14(A) CERTIFICATION dex311.htm EX-31.1 6865
4 SECTION 1350 CERTIFICATION dex32.htm EX-32 3564
5 GRAPHIC g82007g52t30.jpg GRAPHIC 39786
  Complete submission text file 0001193125-10-052735.txt   988489
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: 10-K | Act: 34 | File No.: 000-04829 | Film No.: 10671365
SIC: 2836 Biological Products, (No Diagnostic Substances)